{"_id":"40DkwO7XRDZ8AKM9uw30ayRhl1IUx6xMLnhkUZwkPU0qdDSh9Fr5IH","lastupdate":"2026-03-15T00:00:00.000Z","update_date":"2026-03-15T00:00:00.000Z","lastModified":"Mar 15, 2026","active":1,"confidence_score":37,"confidence_score_reason":"sector, number of employees, tags, invite member, business model, logo, description, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"exocure-therapeutics","minimal_profile":null,"status":"","fullstatus":"","acquired":null,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":null,"name":"Exocure Therapeutics","oneliner":"A novel exosomal cancer treatment","registrar":"517213088","website":"https://exocure-therapeutics.com/","careerspage":"","founded_month":9,"founded_year":2025,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"","employees_exact":null,"patent":null,"raised":0,"stage":"Pre-Funding","public_stage":"Pre-Funding","primary_sector_key":null,"primary_sector":"","alternativenames":null,"about":"ExoCure Therapeutics develops exosome-based cancer therapeutics designed to selectively target tumor pathways while reducing harm to healthy cells.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":"Israel","address":{"israeli":[{"id":"1NJSPd76WijMLXr9qrKW4lQWdNIsEcRberY3rk6r4mHRTR2wWhYaA6","city":"Sakhnin","type":null,"address":"9 Al-Rihana, Sakhnin, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null},{"id":"EDnehYA3pX7iz6lSM4ZvWF3aZYF1JZKTRfhgUoWiy03ZxyKfRYNzNw","city":"3081000","type":null,"address":"אלריחאנה, Sakhnin, 3081000, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":null,"news":[],"newsNumber":0,"events":null,"techcommunityinvolvement":null,"mediagallery":[],"tags":[],"classificationIDs":[],"technologysuccessstory":null,"usecases":[],"businessmodels":[],"productstage":"R&D","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Pre-Funding","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[],"description_edited":null,"tag_line_edited":null,"sector":null,"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Ofir Muchnik","creator_email":"ofirm@sncentral.org","createdate":"2026-03-15T00:00:00.000Z","biverification":null,"sectorverification":null,"affiliatedOrganizations":null,"timeline":[],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"9/2025","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Exocure Therapeutics","logourl":"/assets/startups-icon.svg","oglogourl":"http://localhost/assets/snc_logo.svg","seoabout":"ExoCure Therapeutics develops exosome-based cancer therapeutics designed to selectively target tumor pathways while reducing harm to healthy cells.","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":0,"classifications":[],"classificationDelimited":[],"classificationsViewModel":"|","classificationTrees":{"sector":[],"targetCustomer":[],"coreTechnology":[]},"sectorClassifications":[],"coreTechnologyClassifications":[],"targetCustomerClassifications":[],"classificationNames":{"sector":[],"coreTechnology":[],"targetCustomer":[]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}